Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis

<table>Flow diagram of study selection (from [<a href="/journals/tswj/2014/794078/#B39a">15</a>, <a href="/journals/tswj/2014/794078/#B39b">16</a>]).</table>

The Scientific World Journal

fig1

Figure 1

Figure 1: Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis 

Figure 1 | Benefits and Harms of Extending the Duration of Dual Antiplatelet Therapy after Percutaneous Coronary Intervention with Drug-Eluting Stents: A Meta-Analysis 